Altasciences determines the suitability of nano milling for a client’s highly active compound with very poor aqueous solubility and less than desirable bioavailability.
The Bioequivalence of Fixed-Dose Combination Tablets of Bisoprolol and Ramipril and its Drug-Drug Interaction Potential
Altasciences' scientific experts contribute to an article published in Clinical and Translational Science about clinical development of Bisoprolol/Ramipril fixed-dose combination, for which all three studies were performed at Altasciences.
Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression: A randomized, double-blind, placebo-controlled trial
Dr. Beatrice Setnik, Chief Scientific Officer at Altasciences, contributes to the results and findings from a central nervous system (CNS) study.
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2-4 mg for weight management
Scientific article exploring the results and analysis of a randomized, controlled Phase IB trial conducted by Altasciences and Novo Nordisk A/S published on The Lancet.